Response Statement re “Investors urge food companies to reduce farm antibiotics”

In response to a recent report that a group of investors has contacted food companies asking them to ‘stop their meat and poultry suppliers using antibiotics vital for human health’, the Responsible Use of Medicines in Agriculture Alliance (RUMA) says:

“We recognise concerns about growing resistance to antibiotics, but in humans, resistance is largely attributed to human medical use[i] with a recent study confirming farm animal use could be responsible for as few as one in every 370 clinical cases[ii]. Despite this, resistance is a threat in animals too and the farming industry, as well as those looking after the health of horses and pets, must ‘do its bit’ to control spread.

“The concept that food companies work sustainably with their supply chains to reduce the need for antibiotic use in farm animals is welcomed by RUMA; this is already happening.  However, it’s critical that potential impacts on welfare, food safety, product quality and investment are fully understood by the businesses involved so that farmers have the confidence, means and support to make any necessary changes.

“It is equally important this issue does not end up being exploited as a marketing tool. There is a risk that misrepresentation of facts and a failure to appreciate the situation in different countries could end up harming welfare, cause unnecessary suffering and lead to significant losses in our farm livestock sector.

“For example, while a reported 70% of antibiotics in the US might be used to tackle disease challenges in farm animals, it’s only 40% in the UK, with Public Health England figures[iii] showing medical use of antibiotics is actually 2.4 times that of veterinary, based on kg per biomass (i.e. when corrected for number and weight of animals and people).  Furthermore, use of antibiotics as growth promoters has been banned in the EU since 2006; antibiotics are only available in the UK on prescription from vets; and the industry has already opted for restrictions to use a number of antibiotics classed as critically important for human health, such as 3rd and 4th generation cephalosporins, fluoroquinolones and colistin, only when truly necessary.”

[i] The European Medicines Agency Committee for Medicinal Products for Veterinary Use (CVMP) says in its draft strategy on antimicrobials that: “it is recognized that the biggest driver of AMR in people is the use of antimicrobials in humans or human health.”  Other publications, such as the UK Department of Health 5 Year Strategy on Antimicrobial Resistance, published in 2013, contain similar statements. It stated that whilst antibiotic use in animals is an important factor that: “Increasing scientific evidence suggests that the clinical issues with antimicrobial resistance that we face in human medicine are primarily the result of antibiotic use in people, rather than the use of antibiotics in animals.”

[ii] Burch, D. 2015 – Use of antibiotics in animals and people. November 28, 2015, Veterinary Record, 549-550 doi:10.1136/vr.h6380

[iii] UK One Health Report Joint Report on Human and Animal Antibiotic Use, Sales and Resistance 2013 Public Health England


For further information contact RUMA Secretary General John FitzGerald ( or see the RUMA website

For press enquiries contact Amy Jackson (, 01993 880360, 07917 773756)


  1. RUMA is an alliance of 24 organisations representing every stage of the “farm to fork” process which aims to promote a co-ordinated and integrated approach to best practice in the use of medicines on farm.


  1. RUMA has formulated comprehensive guidelines for the responsible use of antimicrobials in livestock production. These give advice on all aspects from application and responsibilities of the farmer and veterinary surgeon, to strategies for reduced usage.